Table 4.
Adverse drug reactions associated with single tocolytic treatment. Values are numbers (percentages) of women unless stated otherwise
| Tocolytic | No of patients | Severity of adverse drug reaction | Total | Relative risk* (95% CI) | |
|---|---|---|---|---|---|
| Serious | Mild | ||||
| β mimetics | 175 | 3 (1.7) | 4 (2.3) | 7 (4.0) | 3.8 (1.6 to 9.2) |
| Nifedipine | 542 | 5 (0.9) | 6 (1.1) | 11 (2.0) | 2.0 (0.8 to 4.8) |
| Atosiban | 575 | 0 | 1 (0.2) | 1 (0.2) | 0.07 (0.01 to 0.4) |
| Cyclo-oxygenase inhibitors | 35 | 0 | 0 | 0 | NA |
NA=Not applicable.
*For total adverse drug reactions.